三生制药(01530)再涨超7%,高见23.75港元创历史新高。截至发稿,涨7.32%,报23.45港元,成交额9.17亿港元。消息面上,三生制药此前宣布将其自主研发的PD-1/VEGF双特异性抗体SSGJ-707在全球(不包括中国内地)的独家开发、生产、商业化权利授予全球药企巨头辉瑞。根据许可协议,辉瑞将支付12.5亿美元不可退还的首付款,以及最高可达48亿美元的里程碑付款和两位数百分比的销售...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.